Wang J - Search Results

1

Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.

Zheng D, Chen Y, Gao C, Wei Y, Cao G, Lu N, Hou Y, Jiang X, Wang J. Zheng D, et al. Among authors: wang j. Cancer Biol Ther. 2014;15(11):1542-51. doi: 10.4161/15384047.2014.956599. Cancer Biol Ther. 2014. PMID: 25482940 Free PMC article.

2

The methods for determining the purity and in vitro or in vivo activity of recombinant human endostatin.

Zhang HY, Han QW, Xu YF, Fan YR, Dai QM, Xu JM, Zhu HW, Rong ZG, Wang JJ, Xu GX. Zhang HY, et al. Cancer Biol Ther. 2005 Feb;4(2):207-12. Epub 2005 Feb 8. Cancer Biol Ther. 2005. PMID: 15753663

3

Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis.

Fan H, Zhao G, Liu L, Liu F, Gong W, Liu X, Yang L, Wang J, Hou Y. Fan H, et al. Among authors: wang j. Cell Mol Immunol. 2012 Nov;9(6):473-81. doi: 10.1038/cmi.2012.40. Epub 2012 Oct 22. Cell Mol Immunol. 2012. PMID: 23085948 Free PMC article.

4

Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.

Zheng D, Hu Z, He F, Gao C, Xu L, Zou H, Wu Z, Jiang X, Wang J. Zheng D, et al. Among authors: wang j. Oncol Rep. 2014 Jul;32(1):411-8. doi: 10.3892/or.2014.3170. Epub 2014 May 8. Oncol Rep. 2014. PMID: 24807674

5

Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth.

Li X, Fu GF, Fan YR, Liu WH, Liu XJ, Wang JJ, Xu GX. Li X, et al. Cancer Gene Ther. 2003 Feb;10(2):105-11. doi: 10.1038/sj.cgt.7700530. Cancer Gene Ther. 2003. PMID: 12536198

6

Therapeutic efficacy of recombinant human endostatin combined with chemotherapeutics in mice-transplanted tumors.

Zhu LP, Xing J, Wang QX, Kou L, Li C, Hu B, Wu ZW, Wang JJ, Xu GX. Zhu LP, et al. Among authors: wang jj, wang qx. Eur J Pharmacol. 2009 Sep 1;617(1-3):23-7. doi: 10.1016/j.ejphar.2009.07.003. Epub 2009 Jul 16. Eur J Pharmacol. 2009. PMID: 19615993

7

Therapeutic efficacy of Bifidobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mouse-transplanted tumors.

Zhu LP, Yin Y, Xing J, Li C, Kou L, Hu B, Wu ZW, Wang JJ, Xu GX. Zhu LP, et al. Among authors: wang jj. Cancer Sci. 2009 Oct;100(10):1986-90. doi: 10.1111/j.1349-7006.2009.01275.x. Epub 2009 Jul 8. Cancer Sci. 2009. PMID: 19678823 Free PMC article.

8

Preparation of selenium-enriched Bifidobacterium longum and its effect on tumor growth and immune function of tumor-bearing mice.

Yin Y, Wang RR, Wang Y, Wang JJ, Xu GX. Yin Y, et al. Asian Pac J Cancer Prev. 2014;15(8):3681-6. doi: 10.7314/apjcp.2014.15.8.3681. Asian Pac J Cancer Prev. 2014. PMID: 24870777 Free article.

9

Asymmetric siRNA targeting the bcl‑2 gene inhibits the proliferation of cancer cells in vitro and in vivo.

Yin Y, Chen X, Zhang CD, Liu PF, Duan YR, Fan YR, Wu ZW, Fu GF, Wang JJ, Xu GX. Yin Y, et al. Int J Oncol. 2013 Jan;42(1):253-60. doi: 10.3892/ijo.2012.1691. Epub 2012 Nov 7. Int J Oncol. 2013. PMID: 23135004

10

Bioactivity, pharmacokinetics, and immunogenicity assays in preclinical and clinical trials for recombinant human endostatin.

Hu B, Zhu HW, Zhu LP, Li C, Rong ZG, Xu JM, Wu ZW, Wang JJ, Xu GX. Hu B, et al. Acta Pharmacol Sin. 2008 Nov;29(11):1357-69. doi: 10.1111/j.1745-7254.2008.00865.x. Acta Pharmacol Sin. 2008. PMID: 18954531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220,004 results

Search Page

Filters